patient_registry

Next Step for the Patient Registry, a COVID/Pandemic Study

We’d like to thank everyone that has enrolled in the AGS Patient Registry! We’re writing a COVID/Pandemic study now to catalog, among a few other things, experiences with COVID infection and vaccines in AGS. This information will be invaluable to AGS families that have been forced to navigate a difficult pandemic with fears of dangerous comorbidities and a disease stimulated by viruses and (potentially) by COVID vaccines. Based on community feedback, we’ll begin by collecting data about outcomes with COVID vaccines to help build a risk/safety profile that will go along with Dr. Adeline Vanderver’s in vitro experiments with AGS tissue samples and mRNA vaccines.

Have you joined our Facebook Group? AGS families use this group to keep up with information, tips, suggestions, etc. and to talk with the few other people that really understand what living with AGS is like.

AGSAA, Biogen, LunaPBC, and Genetic Alliance Launch Community-Led Discovery Program for Aicardi-Goutières Syndrome

Many of you may already know that we recently launched an AGS patient registry, and we’re actively working with our partners to develop studies and gather insights. This morning we jointly published a press release to let everyone know of our promising collaboration.

 
With committed community engagement and thoughtful stewardship of our data, we will finally have what we need to tell our story and begin to write a different ending.
— Devon Cordova, Vice President, AGSAA